Table 1.
Patient characteristics
| Patient | Age | Gender | Genotype | Indication |
| 1 | 50 | F | HbSS | RPC |
| 2 | 27 | M | HbSS | RPC |
| 3 | 40 | M | HbSS | RPC |
| 4 | 53 | F | HbSβ0 | RPC |
| 5 | 48 | F | HbSS | RPC |
| 6 | 33 | M | HbSβ0 | SSP* |
| 7 | 27 | M | HbSS | RPC |
| 8 | 48 | M | HbEβ0 | Improving anaemia |
| 9 | 30 | M | HbSS | RPC |
| 10 | 56 | M | HbSC | RPC |
| 11 | 31 | M | HbSS | RACS |
| 12 | 44 | F | HbSS | RPC |
| 13 | 33 | F | HbSC | RPC |
| 14 | 32 | F | HbSS | RPC |
| 15 | 30 | M | HbSS | SSP* |
| 16 | 32 | M | HbSS | RPC |
| 17 | 24 | M | HbSS | RPC |
| 18 | 51 | F | HbSS | SCN |
| 19 | 67 | F | HbSC | RPC |
| 20 | 20 | F | HbSS | RPC |
| 21 | 47 | F | HbSS | RPC |
| 22 | 47 | F | HbSS | RPC |
| 23 | 34 | F | HbSS | RPC |
| 24 | 33 | F | HbSS | RPC |
| 25 | 42 | F | HbSS | RPC |
| 26 | 27 | F | HbSS | RPC |
| 27 | 25 | M | HbSS | RPC |
| 28 | 48 | F | HbSS | RPC |
| 29 | 44 | F | HbSS | RPC |
| 30 | 44 | F | HbSS | RPC |
| 31 | 23 | F | HbSS | RPC |
*Secondary stroke prevention, transfusions declined/contraindicated.
RACS, recurrent acute chest syndrome; RPC, recurrent painful crises; SCN, sickle cell nephropathy; SSP, secondary stroke prevention.